|
Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) DCF Valuation
CN | Healthcare | Biotechnology | SHZ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) Bundle
Enhance your investment strategies with the (300122SZ) DCF Calculator! Utilize genuine financial data for Chongqing Zhifei Biological Products Co., Ltd., adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of (300122SZ).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10,587.3 | 15,190.4 | 30,652.4 | 38,264.0 | 52,917.8 | 54,810.9 | 56,771.8 | 58,802.8 | 60,906.5 | 63,085.4 |
| Revenue Growth, % | 0 | 43.48 | 101.79 | 24.83 | 38.3 | 3.58 | 3.58 | 3.58 | 3.58 | 3.58 |
| EBITDA | 2,930.0 | 4,102.1 | 12,393.1 | 9,086.2 | 9,747.0 | 15,048.4 | 15,586.8 | 16,144.4 | 16,722.0 | 17,320.2 |
| EBITDA, % | 27.67 | 27 | 40.43 | 23.75 | 18.42 | 27.46 | 27.46 | 27.46 | 27.46 | 27.46 |
| Depreciation | 96.6 | 131.4 | 388.9 | 330.8 | 323.7 | 495.7 | 513.5 | 531.8 | 550.9 | 570.6 |
| Depreciation, % | 0.91203 | 0.8652 | 1.27 | 0.8646 | 0.61171 | 0.90443 | 0.90443 | 0.90443 | 0.90443 | 0.90443 |
| EBIT | 2,833.4 | 3,970.7 | 12,004.2 | 8,755.4 | 9,423.3 | 14,552.7 | 15,073.3 | 15,612.6 | 16,171.1 | 16,749.7 |
| EBIT, % | 26.76 | 26.14 | 39.16 | 22.88 | 17.81 | 26.55 | 26.55 | 26.55 | 26.55 | 26.55 |
| Total Cash | 1,150.1 | 1,437.5 | 4,307.8 | 2,622.1 | 6,340.5 | 5,833.4 | 6,042.1 | 6,258.3 | 6,482.2 | 6,714.1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 4,500.5 | 6,633.2 | 12,874.4 | 20,622.3 | 27,058.6 | 25,564.4 | 26,478.9 | 27,426.2 | 28,407.4 | 29,423.7 |
| Account Receivables, % | 42.51 | 43.67 | 42 | 53.89 | 51.13 | 46.64 | 46.64 | 46.64 | 46.64 | 46.64 |
| Inventories | 2,484.5 | 3,405.6 | 7,385.4 | 8,020.5 | 8,986.0 | 11,830.6 | 12,253.8 | 12,692.2 | 13,146.3 | 13,616.6 |
| Inventories, % | 23.47 | 22.42 | 24.09 | 20.96 | 16.98 | 21.58 | 21.58 | 21.58 | 21.58 | 21.58 |
| Accounts Payable | 2,222.5 | 3,084.4 | 9,178.4 | 9,807.3 | 13,141.9 | 13,341.6 | 13,818.9 | 14,313.3 | 14,825.4 | 15,355.8 |
| Accounts Payable, % | 20.99 | 20.3 | 29.94 | 25.63 | 24.83 | 24.34 | 24.34 | 24.34 | 24.34 | 24.34 |
| Capital Expenditure | -572.9 | -827.0 | -1,932.1 | -1,453.1 | -1,134.2 | -2,532.2 | -2,622.8 | -2,716.7 | -2,813.8 | -2,914.5 |
| Capital Expenditure, % | -5.41 | -5.44 | -6.3 | -3.8 | -2.14 | -4.62 | -4.62 | -4.62 | -4.62 | -4.62 |
| Tax Rate, % | 13.62 | 13.62 | 13.62 | 13.62 | 13.62 | 13.62 | 13.62 | 13.62 | 13.62 | 13.62 |
| EBITAT | 2,424.7 | 3,401.2 | 10,271.2 | 7,571.3 | 8,139.8 | 12,505.2 | 12,952.5 | 13,415.9 | 13,895.9 | 14,393.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2,814.1 | 513.7 | 4,601.0 | -1,305.0 | 3,262.2 | 9,318.0 | 9,982.7 | 10,339.8 | 10,709.7 | 11,092.9 |
| WACC, % | 8.79 | 8.79 | 8.79 | 8.79 | 8.79 | 8.79 | 8.79 | 8.79 | 8.79 | 8.79 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 39,952.0 | |||||||||
| Long Term Growth Rate, % | 3.50 | |||||||||
| Free cash flow (T + 1) | 11,481 | |||||||||
| Terminal Value | 216,897 | |||||||||
| Present Terminal Value | 142,312 | |||||||||
| Enterprise Value | 182,264 | |||||||||
| Net Debt | -3,305 | |||||||||
| Equity Value | 185,570 | |||||||||
| Diluted Shares Outstanding, MM | 2,400 | |||||||||
| Equity Value Per Share | 77.32 |
What You'll Receive
- Customizable Excel Template: A tailored Excel-based DCF Calculator featuring pre-loaded financial data for Chongqing Zhifei Biological Products Co., Ltd. (300122SZ).
- Real Data Insights: Access to historical figures and future projections (highlighted in the yellow cells).
- Flexible Forecasting: Adjust key assumptions such as revenue growth, EBITDA %, and WACC to suit your analysis.
- Instant Calculations: Observe real-time effects of your inputs on the valuation of Chongqing Zhifei Biological Products Co., Ltd. (300122SZ).
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Layout: Organized for ease of understanding and use, complete with step-by-step guidance.
Key Features
- Customizable Forecast Variables: Adjust essential factors such as revenue growth, EBITDA percentage, and capital expenditure.
- Instant DCF Valuation: Quickly computes intrinsic value, Net Present Value (NPV), and various other financial metrics.
- High-Precision Accuracy: Leverages real-world financial data from Chongqing Zhifei Biological Products Co., Ltd. for credible valuation results.
- Simplified Scenario Analysis: Evaluate diverse assumptions and easily compare the results.
- Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review the pre-filled data for Chongqing Zhifei Biological Products Co., Ltd. (300122SZ).
- Step 3: Modify key assumptions (highlighted in yellow) according to your insights.
- Step 4: Observe the automatic recalculations reflecting the intrinsic value of Chongqing Zhifei Biological Products Co., Ltd. (300122SZ).
- Step 5: Utilize the results for making investment decisions or for reporting purposes.
Why Opt for This Calculator?
- User-Friendly: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Easily adjust parameters to suit your analysis needs.
- Real-Time Updates: Monitor immediate changes to Chongqing Zhifei's valuation as you tweak inputs.
- Pre-Loaded Data: Comes with Chongqing Zhifei’s actual financial metrics for swift evaluation.
- Preferred by Experts: Utilized by investors and analysts to make sound decisions.
Who Should Consider This Product?
- Individual Investors: Make well-informed choices regarding the purchase or sale of Chongqing Zhifei Biological Products Co., Ltd. (300122SZ) shares.
- Financial Analysts: Enhance valuation processes using efficient financial models tailored for the biopharmaceutical sector.
- Consultants: Provide timely and accurate valuation insights to clients in the biotechnology industry.
- Business Owners: Gain a deeper understanding of how companies like Chongqing Zhifei (300122SZ) are valued to inform your own strategic decisions.
- Finance Students: Explore valuation methodologies using real-time data and relevant case studies.
What the Template Includes
- Historical Data: Contains Chongqing Zhifei’s previous financial metrics and foundational forecasts.
- DCF and Levered DCF Models: Comprehensive templates for assessing the intrinsic value of Chongqing Zhifei.
- WACC Sheet: Pre-configured calculations for Weighted Average Cost of Capital.
- Editable Inputs: Adjust essential variables such as growth rates, EBITDA percentages, and CAPEX projections.
- Quarterly and Annual Statements: A thorough analysis of Chongqing Zhifei’s financial performance.
- Interactive Dashboard: Dynamically visualize valuation outcomes and forecasts.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.